According to the American Heart Association (AHA), 15% to 20% of strokes are linked to atrial fibrillation (AF), a heart rhythm disorder that will affect more than 12 million Americans by 2030.

One option for managing AF is the WATCHMAN™ implant. Developed by Boston Scientific, this innovative procedure offers a safer and more effective alternative to long-term blood thinners.

The WATCHMAN™ implant is designed to reduce stroke risk for AF patients by permanently closing off the left atrial appendage, where blood clots commonly form. Dr. Rishi Anand explains how this minimally invasive procedure works, helping patients regain control of their health with fewer lifestyle restrictions.

Ready to explore if the WATCHMAN™ is right for you? Watch as Dr Anand explains what it is all about. 

Learn more about atrial fibrillation and stroke risk in our health library. 

Take our heart health assessment today.